Eterna Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanjeev Luther, with a market cap of $6.0M.
Common questions about Eterna Therapeutics
Eterna Therapeutics is scheduled to report earnings for Q1 2026 on May 6, 2026.
Eterna Therapeutics has approximately 8 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.